Search Results | Clinical Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers

Sanja Stevanović, Sarah R. Helman, John R. Wunderlich, Michelle M. Langhan, Stacey L. Doran, Mei Li M. Kwong, Robert P.T. Somerville, Christopher A. Klebanoff, Udai S. Kammula, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Christian S. Hinrichs

Clin Cancer Res (2019) 25 (5): 1486–1493.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-2722

Published: 01 March 2019

View article

Includes: Supplementary data

Journal Articles

T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers

Drew C. Deniger, Anna Pasetto, Paul F. Robbins, Jared J. Gartner, Todd D. Prickett, Biman C. Paria, Parisa Malekzadeh, Li Jia, Rami Yossef, Michelle M. Langhan, John R. Wunderlich, David N. Danforth, Robert P.T. Somerville, Steven A. Rosenberg

Clin Cancer Res (2018) 24 (22): 5562–5573.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-0573

Published: 15 November 2018

View article

Includes: Supplementary data

Journal Articles

Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer

Yasmine Assadipour, Nikolaos Zacharakis, Jessica S. Crystal, Todd D. Prickett, Jared J. Gartner, Robert P.T. Somerville, Hui Xu, Mary A. Black, Li Jia, Harshini Chinnasamy, Isaac Kriley, Lily Lu, John R. Wunderlich, Zhili Zheng, Yong-Chen Lu, Paul F. Robbins, Steven A. Rosenberg, Stephanie L. Goff, Steven A. Feldman

Clin Cancer Res (2017) 23 (15): 4347–4353.

DOI: https://doi.org/10.1158/1078-0432.CCR-16-1423

Published: 01 August 2017

View article

Includes: Supplementary data

Journal Articles

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

Drew C. Deniger, Mei Li M. Kwong, Anna Pasetto, Mark E. Dudley, John R. Wunderlich, Michelle M. Langhan, Chyi-Chia Richard Lee, Steven A. Rosenberg

Clin Cancer Res (2017) 23 (2): 351–362.

DOI: https://doi.org/10.1158/1078-0432.CCR-16-0906

Published: 15 January 2017

View article

Journal Articles

Identification of an Immunogenic Subset of Metastatic Uveal Melanoma

Luke D. Rothermel, Arvind C. Sabesan, Daniel J. Stephens, Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Robert Somerville, John R. Wunderlich, Chyi-Chia R. Lee, Liqiang Xi, Trinh H. Pham, Mark Raffeld, Parthav Jailwala, Manjula Kasoji, Udai S. Kammula

Clin Cancer Res (2016) 22 (9): 2237–2249.

DOI: https://doi.org/10.1158/1078-0432.CCR-15-2294

Published: 01 May 2016

View article

Includes: Supplementary data

Journal Articles

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Jessica S. Crystal, Richard A. Morgan, Steven A. Feldman, James C. Yang, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi-Chia R. Lee, Yong F. Li, Mona El-Gamil, Steven A. Rosenberg

Clin Cancer Res (2015) 21 (5): 1019–1027.

DOI: https://doi.org/10.1158/1078-0432.CCR-14-2708

Published: 01 March 2015

View article

Includes: Supplementary data

Journal Articles

Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula

Clin Cancer Res (2015) 21 (3): 534–543.

DOI: https://doi.org/10.1158/1078-0432.CCR-14-2208

Published: 01 February 2015

View article

Includes: Supplementary data

Journal Articles

Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Edmund K. Bartlett, Patricia A. Fetsch, Armando C. Filie, Andrea Abati, Seth M. Steinberg, John R. Wunderlich, Donald E. White, Daniel J. Stephens, Francesco M. Marincola, Steven A. Rosenberg, Udai S. Kammula

Clin Cancer Res (2014) 20 (10): 2607–2616.

DOI: https://doi.org/10.1158/1078-0432.CCR-13-2690

Published: 14 May 2014

View article

Includes: Supplementary data

Journal Articles

Tumor-Reactive CD8⁺ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy

Simon Turcotte, Alena Gros, Eric Tran, Chyi-Chia R. Lee, John R. Wunderlich, Paul F. Robbins, Steven A. Rosenberg

Clin Cancer Res (2014) 20 (2): 331–343.

DOI: https://doi.org/10.1158/1078-0432.CCR-13-1736

Published: 16 January 2014

View article

Includes: Supplementary data

Journal Articles

Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy

Rachel E. Beard, Daniel Abate-Daga, Shannon F. Rosati, Zhili Zheng, John R. Wunderlich, Steven A. Rosenberg, Richard A. Morgan

Clin Cancer Res (2013) 19 (18): 4941–4950.

DOI: https://doi.org/10.1158/1078-0432.CCR-13-1253

Published: 16 September 2013

View article

Includes: Supplementary data

Journal Articles

Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma

Alena Gros, Simon Turcotte, John R. Wunderlich, Mojgan Ahmadzadeh, Mark E. Dudley, Steven A. Rosenberg

Clin Cancer Res (2012) 18 (19): 5212–5223.

DOI: https://doi.org/10.1158/1078-0432.CCR-12-1108

Published: 30 September 2012

View article

Includes: Supplementary data

Journal Articles

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurencot, Seth M. Steinberg, Donald E. White, Mark E. Dudley

Clin Cancer Res (2011) 17 (13): 4550–4557.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-0116

Published: 05 July 2011

View article

Includes: Supplementary data

Journal Articles

CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

Clin Cancer Res (2010) 16 (24): 6122–6131.

DOI: https://doi.org/10.1158/1078-0432.CCR-10-1297

Published: 16 December 2010

View article

Includes: Supplementary data

Journal Articles

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker, Gang Wang, Zelig Eshhar, Sharon A. Mavroukakis, Donald E. White, John R. Wunderlich, Silvana Canevari, Linda Rogers-Freezer, Clara C. Chen, James C. Yang, Steven A. Rosenberg, Patrick Hwu

Clin Cancer Res (2006) 12 (20): 6106–6115.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-1183

Published: 24 October 2006

View article

Journal Articles

Intralymphatic Dendritic Cell Vaccination Induces Tumor Antigen–Specific, Skin-Homing T Lymphocytes

Amelia Grover, Grace J. Kim, Gregory Lizée, Mary Tschoi, Gang Wang, John R. Wunderlich, Steven A. Rosenberg, Sam T. Hwang, Patrick Hwu

Clin Cancer Res (2006) 12 (19): 5801–5808.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-2421

Published: 04 October 2006

View article

Journal Articles

Recombinant Fowlpox Viruses Encoding the Anchor-modified gp100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma

Steven A. Rosenberg, James C. Yang, Douglas J. Schwartzentruber, Patrick Hwu, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, John R. Wunderlich, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon A. Mavroukakis, Linda Gritz, Dennis L. Panicali, Donald E. White

Clin Cancer Res (2003) 9 (8): 2973–2980.

Published: 11 August 2003

View article

NARROW

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers

T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers

Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

Identification of an Immunogenic Subset of Metastatic Uveal Melanoma

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Tumor-Reactive CD8⁺ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy

Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy

Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Intralymphatic Dendritic Cell Vaccination Induces Tumor Antigen–Specific, Skin-Homing T Lymphocytes

Recombinant Fowlpox Viruses Encoding the Anchor-modified gp100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only